Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$693K Sell
2,474
-13,512
-85% -$3.55M 0.03% 159
2026
Q1
$4.27M Buy
+15,986
New +$4.33M 0.17% 126
2023
Q3
Sell
-268
Closed -$55.5K 144
2023
Q2
$55.5K Sell
268
-455
-63% -$88.3K 0.01% 147
2023
Q1
$142K Buy
+723
New +$149K 0.02% 138

Other funds holding LH

Mirova's LH Position: Q2 2026 in Review

Mirova reduced its Labcorp (LH) stake by 85% in Q2 2026, selling an estimated $3.55M and leaving 2,474 shares worth $693K. The position accounts for 0.03% of the portfolio, ranked #159.

Mirova first reported a position in LH in Q1 2023 and has held it in 4 quarters since. The position peaked at $4.27M in Q1 2026. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Mirova held 2,474 shares of Labcorp worth $693K as of Q2 2026.
  • Mirova sold 13,512 Labcorp shares in Q2 2026, an estimated $3.55M.
  • Labcorp made up 0.03% of Mirova's portfolio in Q2 2026, its #159 holding.
  • Mirova first reported a position in Labcorp in Q1 2023 and has held it in 4 quarters since.
  • Mirova's Labcorp position peaked at $4.27M in Q1 2026.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Mirova's 13F filing for Q2 2026, filed 13 Aug 2026.